BMSEED: News
BMSEED is committed to driving innovation and creating a positive impact on the biomedical research community. Our mission is to develop and provide state-of-the-art devices that empower researchers, biomedical scientists, and healthcare professionals to push the boundaries of scientific discovery. Through our cutting-edge technologies, including stretchable microelectrode arrays and advanced cell-stretching systems, we aim to facilitate more effective and efficient biomedical studies. Our focus is on supporting the advancement of biomedical science, fostering collaboration, and enabling groundbreaking research that can transform healthcare. Whether through partnerships, product innovation, or knowledge sharing, BMSEED is dedicated to shaping the future of biomedicine.
Reach Out to BMSEED
Contact us at BMSEED if you're interested in the MEASSuRE system. Our team will walk you through how this tool can support and enhance your research.
BMSEED Chooses Intellectual Property Law Firm BSKB
BMSEED was recently awarded $50,000 from the NIH Small Business Phase II Technical and Business Assistance (TABA) Consulting Services program with the goal to strengthen the company’s IP portfolio.
BMSEED Accepted to NIH TABA Consulting Services Program
BMSEED was awarded consulting services for intellectual property through the TABA Consulting Services Program.
BMSEED Awarded Phase I SBIR Grant from NIH
BMSEED recieved a Phase I SBIR award from the NIH for the commercialization of an organoid pocket microelectrode arrays.
BMSEED Partnering with BU to Develop Nanoclip Peripheral Nerve Interface
BMSEED is partnering with Boston University to develop a nanoclip peripheral nerve interface (ncPNI) for more biomechanically compatible neuroprostheses in fine nerve tissues.
BMSEED Receives Phase II SBIR Award from NIH
BMSEED received a Phase II SBIR award from the NIH for the commercialization of stretchable microelectrode arrays.
BMSEED Awarded $568,982 Phase I SBIR from NINDS
BMSEED received a Phase I SBIR from NINDS to develop a novel electrode array for electrocorticography to improve brain-machine interfaces and outcomes of epilepsy surgeries ($568,982).